Welcome : Guest

Trillium Therapeutics, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Trillium Therapeutics, Inc., which is principally an Immuno-Oncology Company. Illustrated with 48 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-28829
Price: $2400
Company Type: Public
Pages: 50
Date: January 2016
Market Data Tables: 48

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......2
Table 1: Biopharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......2
Table 2: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......3
Table 3: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......4
Table 4: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......5
Table 5: Proteins Market by Segment in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibody (MAb), Nerve Growth Factor (NGF), and Somatropin......6
Oncology Market......7
Table 6: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......7
Table 7: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......8
Table 8: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......9
Table 9: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......10
Table 10: Cancer-Associated Mucositis Market by Activity Worldwide (2015) – Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......11
Table 11: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......12
Table 12: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......13
Table 13: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......14
Table 14: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......15
Table 15: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......16
Table 16: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......17
Cancer Patients......18
Table 17: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......18
Table 18: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......19
Table 19: No. of Primary Liver Cancer Patients by Region Worldwide (2015) – Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Table 20: No. of Patients for Immunotherapy by Region Worldwide (2015) – Percentage Market Share Breakdown by Value for Europe, North America, and Others......21
Table 21: Immune Tolerance Therapy (Patient) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......22
Table 22: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......23
Table 23: New Patients with Cancer in Stage 3/4 by Site in the US (2015) – Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......24
Table 24: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......25
Table 25: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......26
Table 26: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......27
Table 27: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......28
Table 28: No. of Bladder Cancer Patients by Category in the US (2014) – Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......29
Table 29: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......30
Table 30: No. of Non Small Cell Lung Cancer Patients by Category in the US (2014) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......31
Table 31: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......32
Table 32: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......33
Table 33: No. of Patients for Immunotherapy by Age Group in the US (2015) - Percentage Market Share Breakdown by Value for 0-4 Patient Pool, 10 - 14 Patient Pool, 15 - 19 Patient Pool, 5-9 Patient Pool, Adult Patient Pool (over 65), and Adult Patient Pool (under 65)......34
Table 34: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......35
Cancer Mortality......36
Table 35: Female Mortality by Cancer Type in China (2014) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......36
Table 36: Male Mortality by Cancer Type in China (2014) - Percentage Market Share Breakdown by Volume for Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......37
Cancer Drugs......38
Table 37: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......38
Table 38: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......39
Table 39: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......40
Skin Cancer Drugs......41
Table 40: Dermatological Drug Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......41
Gastric Cancer Drugs......42
Table 41: Margetuximab Market for Gastric Cancer by Region Worldwide (2015) - Percentage Share Breakdown by Value for United States, European Union and Rest Of World......42
Biopharmaceuticals......43
Table 42: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......43
Table 43: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., North China Pharmaceutical Group Corporation Shanghai Fosun Pharmaceutical Group Co., Ltd., and Others......44
Oncology Drugs......45
Table 44: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......45
Table 45: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......46
Table 46: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......47
Table 47: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......48
Nausea and Vomiting Associated With Cancer Chemotherapy......49
Table 48: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......49